Eterna Therapeutics
ERNA
#10102
Rank
S$13.29 M
Marketcap
$0.25
Share price
4.48%
Change (1 day)
-91.72%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of April 2025 (TTM): 16.5

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.64. At the end of 2024 the company had a P/S ratio of 22.3.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202422.3-84.36%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.17-92.90%๐Ÿ‡บ๐Ÿ‡ธ USA
11.0-33.25%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
2.65-83.92%๐Ÿ‡ซ๐Ÿ‡ท France
7.05-57.23%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2168-98.68%๐Ÿ‡ฆ๐Ÿ‡บ Australia
0.9663-94.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel